UT-15C SR, Peripheral Vascular Disease, treprostinil
Showing 1 - 25 of >10,000
Pulmonary Arterial Hypertension Trial in Worldwide (UT-15C (treprostinil diolamine))
Completed
- Pulmonary Arterial Hypertension
- UT-15C (treprostinil diolamine)
-
Phoenix, Arizona
- +152 more
May 6, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Oral Treprostinil)
Completed
- Pulmonary Arterial Hypertension
- Oral Treprostinil
-
Birmingham, Alabama
- +134 more
Apr 14, 2021
Raynaud's Phenomenon Trial in Boston (oral treprostinil, Placebo)
Completed
- Raynaud's Phenomenon
- oral treprostinil
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2022
Pulmonary Hypertension, COPD Trial in Israel, United States (Inhaled treprostinil solution)
Terminated
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled treprostinil solution
-
Birmingham, Alabama
- +29 more
Jan 5, 2023
Systemic Sclerosis, Calcinosis Trial in Palo Alto (Oral treprostinil)
Completed
- Systemic Sclerosis
- Calcinosis
- Oral treprostinil
-
Palo Alto, CaliforniaStanford University School of Medicine
Jun 8, 2021
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial in Puerto Rico, United States
Completed
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- Placebo
-
Birmingham, Alabama
- +96 more
Jul 21, 2022
Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)
Withdrawn
- Atherosclerosis of Artery
- +4 more
- N-acetylcysteine
- Placebo
-
Changsha, Hunan, China
- +1 more
Jun 9, 2023
Acute Kidney Injury, Uremic; Toxemia, Vascular Dysfunction Trial in Amiens (blood sample)
Recruiting
- Acute Kidney Injury
- +4 more
- blood sample
-
Amiens, FranceAmiens hospital
Dec 13, 2022
Single Ventricle Trial in Palo Alto (Treprostinil)
Terminated
- Single Ventricle
-
Palo Alto, CaliforniaLucile Packard Children's Hospital, Stanford
Mar 8, 2022
Peripheral Arterial Resistive Index in Evaluation of Tissue
Completed
- Shock, Septic
- hemodynamic monitoring
- +2 more
-
Fatih, İstanbul, TurkeyBezmialem Vakıf University
Jun 12, 2023
Peripheral Arterial Disease Trial in Orange (VibratoSleeve Therapeutic Ultrasound Device)
Recruiting
- Peripheral Arterial Disease
- VibratoSleeve Therapeutic Ultrasound Device
-
Orange, CaliforniaVascular & Interventional Specialists of Orange County
May 24, 2023
Critical Limb Ischemia, Peripheral Arterial Disease Trial in Kuala Lumpur (Stempeucel®)
Not yet recruiting
- Critical Limb Ischemia
- Peripheral Arterial Disease
- Stempeucel®
-
Kuala Lumpur, MalaysiaHospital Canselor Tunku Mukhriz
May 2, 2023
Arbovirus Infections Trial in Colombo, Ragama (Transfluthrin, Placebo)
Not yet recruiting
- Arbovirus Infections
- Transfluthrin
- Placebo
-
Colombo, West, Sri Lanka
- +1 more
Jul 6, 2022
Anthracycline-based Chemotherapy on Peripheral Vascular Function
Completed
- Breast Cancer
- +2 more
- Arterial blood pressure
- +3 more
-
Manhattan, KansasLafene Health Center
Mar 30, 2022
Healthy, Physical Activity Trial in Madison (Control, Aerobic Exercise)
Completed
- Healthy
- Physical Activity
- Control
- Aerobic Exercise
-
Madison, WisconsinGymnasium-Natatorium
Jun 20, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Treprostinil Palmitil
- Placebo
-
West Hollywood, California
- +43 more
Jul 21, 2022
Vascular Complications in Children From T1D Diagnosis
Not yet recruiting
- Type 1 Diabetes
- +3 more
- (no location specified)
Mar 16, 2023
Peripheral Arterial Disease, Atherosclerosis of Extremities, Inflammation Trial in Hamilton (Colchicine 0.5 MG Oral Tablet,
Recruiting
- Peripheral Arterial Disease
- +2 more
- Colchicine 0.5 MG Oral Tablet
- Colchicine-Placebo
-
Hamilton, Ontario, CanadaHamilton General Hospital
Sep 14, 2021
Hemodynamic Stability Trial in Assiut (Bupivacaine 0.5% Injectable Solution, Prilocaine Hydrochloride 2% Injection)
Recruiting
- Hemodynamic Stability
- Bupivacaine 0.5% Injectable Solution
- Prilocaine Hydrochloride 2% Injection
-
Assiut, Assuit, EgyptAssuit university
May 17, 2023
COVID-19 Pneumonia Trial in Lumezzane (Single passive leg movement)
Completed
- COVID-19 Pneumonia
- Single passive leg movement
-
Lumezzane, Brescia, ItalyICS Maugeri IRCCS, U.O. Emergenza Coronavirus di Lumezzane
Apr 7, 2022
Vascular Access Device Complications Trial in Milwaukee (Long Peripheral Catheter, Peripherally Inserted Central Catheter)
Recruiting
- Vascular Access Device Complications
- Long Peripheral Catheter
- Peripherally Inserted Central Catheter
-
Milwaukee, WisconsinChildren's Wisconsin
Aug 10, 2022
B-type Natriuretic Peptide With N-terminal Pro B-type
Recruiting
- Perioperative Care
- NT ProBNP (Roche)
-
Kingston, Ontario, CanadaKingston Health Sciences Centre
Jun 29, 2022
Metabolic Syndrome Trial in Charlottesville (Low Intensity Exercise + Metformin, High Intensity Exercise + Metformin, Low
Active, not recruiting
- Metabolic Syndrome
- Low Intensity Exercise + Metformin
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Dec 6, 2022
Peripheral Arterial Disease, Sedentary Behavior, Sedentary Time Trial in Galway (RESPONSE-2-PAD)
Not yet recruiting
- Peripheral Arterial Disease
- +3 more
- RESPONSE-2-PAD
-
Galway, IrelandNational Institute for prevention and Cardiovascular Health
Jul 18, 2023
Peripheral Arterial Disease, Peripheral Vascular Diseases Trial in New Haven (Problem Solving Therapy and Integrated Care)
Recruiting
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Problem Solving Therapy and Integrated Care
-
New Haven, ConnecticutYale New Haven Health Hospital
Feb 23, 2023